-
DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.
Wu L, McNeely J, Subramaniam GA, Brady KT, Sharma G, VanVeldhuisen PC, Zhu H, Schwartz RP. DSM-5 substance use disorders among adult primary care patients: Results from a multisite study. Drug and Alcohol Dependence 2017;179:42-46.
-
Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.
Hser Y, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou C, Gray KM. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 2017;81:53-58.
-
Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016.
Guydish JR, Yip D, Le T, Gubner N, Delucchi KL, Roman PM. Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016. Drug and Alcohol Dependence 2017;179:355-361.
-
Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults.
Lee JD, Tofighi B, McDonald R, Campbell ANC, Hu M, Nunes EV. Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults. Health and Justice 2017;5:3,1-9.
-
The effect of partly missing covariates on statistical power in randomized controlled trials with discrete-time survival endpoints.
Jolani S, Safarkhani M. The effect of partly missing covariates on statistical power in randomized controlled trials with discrete-time survival endpoints. Methodology 2017;13:41-60.
-
Chronic pain among patients with opioid use disorder: Results from electronic health records data.
Hser Y, Mooney LJ, Saxon AJ, Miotto A, Bell DS, Huang D. Chronic pain among patients with opioid use disorder: Results from electronic health records data. Journal of Substance Abuse Treatment 2017;77:26–30
-
High mortality among patients with opioid use disorder in a large healthcare system.
Hser Y, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, Liang D, Huang D. High mortality among patients with opioid use disorder in a large healthcare system. Journal of Addiction Medicine 2017;11(4):315-319.
-
Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.
Campbell BK, Le T, Tajima BM, Guydish JR. Quitting smoking during substance use disorders treatment: Patient and treatment-related variables. Journal of Substance Abuse Treatment 2017;73:40-46.
-
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: A pilot/feasibility randomized trial.
Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: A pilot/feasibility randomized trial. Addiction 2017;112(6):1036-1044.
-
Predictive validity of addiction treatment clinicians’ post-training contingency management skills for subsequent clinical outcomes.
Hartzler B, Beadnell B, Donovan DM. Predictive validity of addiction treatment clinicians' post-training contingency management skills for subsequent clinical outcomes. Journal of Substance Abuse Treatment 2017;72:126-133.